Diagnamed Holdings Corp. (CSE:DMED)

Canada flag Canada · Delayed Price · Currency is CAD
0.1100
-0.0050 (-4.35%)
Oct 9, 2025, 3:46 PM EDT
-4.35%
Market Cap12.01M
Revenue (ttm)n/a
Net Income (ttm)-1.13M
Shares Out109.16M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,084,973
Average Volume627,980
Open0.1200
Previous Close0.1150
Day's Range0.1050 - 0.1250
52-Week Range0.0050 - 0.1300
Beta-1.12
RSI61.99
Earnings DateJan 30, 2026

About Diagnamed Holdings

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdi... [Read more]

Sector Healthcare
CEO John Karagiannidis
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.